Suppr超能文献

相似文献

1
Evidence that high von Willebrand factor and low ADAMTS-13 levels independently increase the risk of a non-fatal heart attack.
J Thromb Haemost. 2008 Apr;6(4):583-8. doi: 10.1111/j.1538-7836.2008.02902.x. Epub 2008 Jan 11.
2
ADAMTS13 and von Willebrand factor and the risk of myocardial infarction in men.
Blood. 2007 Mar 1;109(5):1998-2000. doi: 10.1182/blood-2006-07-038166. Epub 2006 Oct 19.
4
ADAMTS-13 and von Willebrand factor predict venous thromboembolism in patients with cancer.
J Thromb Haemost. 2016 Feb;14(2):306-15. doi: 10.1111/jth.13205. Epub 2016 Jan 25.
5
Impact of the von Willebrand factor-ADAMTS-13 axis on the risk of future venous thromboembolism.
J Thromb Haemost. 2023 May;21(5):1227-1237. doi: 10.1016/j.jtha.2023.01.024. Epub 2023 Feb 1.
9
Changes in von Willebrand factor and ADAMTS-13 in patients following arthroplasty.
Mol Med Rep. 2015 Apr;11(4):3015-20. doi: 10.3892/mmr.2014.3041. Epub 2014 Dec 3.

引用本文的文献

2
Optimization of plasma-based BioID identifies plasminogen as a ligand of ADAMTS13.
Sci Rep. 2024 Apr 20;14(1):9073. doi: 10.1038/s41598-024-59672-6.
4
5
Circulating ADAMTS13 Levels Are Associated with an Increased Occurrence of Obstructive Sleep Apnea.
Dis Markers. 2022 Mar 29;2022:1504137. doi: 10.1155/2022/1504137. eCollection 2022.
6
Blood Group O Protect End-Stage Renal Disease Patients With Dialysis From Coronary Artery Disease.
Front Cardiovasc Med. 2022 Jan 28;8:821540. doi: 10.3389/fcvm.2021.821540. eCollection 2021.
7
Association between ADAMTS13 deficiency and cardiovascular events in chronic hemodialysis patients.
Sci Rep. 2021 Nov 24;11(1):22816. doi: 10.1038/s41598-021-02264-5.
8
Verification of the Role of ADAMTS13 in the Cardiovascular Disease Using Two-Sample Mendelian Randomization.
Front Genet. 2021 Jul 1;12:660989. doi: 10.3389/fgene.2021.660989. eCollection 2021.
9
Von Willebrand factor, ADAMTS13 and mortality in dialysis patients.
BMC Nephrol. 2021 Jun 16;22(1):222. doi: 10.1186/s12882-021-02420-z.
10
Crystal structure of ADAMTS13 CUB domains reveals their role in global latency.
Sci Adv. 2021 Apr 16;7(16). doi: 10.1126/sciadv.abg4403. Print 2021 Apr.

本文引用的文献

1
Serial changes in von Willebrand factor-cleaving protease (ADAMTS13) and prognosis after acute myocardial infarction.
Am J Cardiol. 2007 Sep 1;100(5):758-63. doi: 10.1016/j.amjcard.2007.03.095. Epub 2007 Jun 12.
2
ADAMTS13 and von Willebrand factor and the risk of myocardial infarction in men.
Blood. 2007 Mar 1;109(5):1998-2000. doi: 10.1182/blood-2006-07-038166. Epub 2006 Oct 19.
3
Reduced von Willebrand factor-cleaving protease (ADAMTS13) activity in acute myocardial infarction.
J Thromb Haemost. 2006 Nov;4(11):2490-3. doi: 10.1111/j.1538-7836.2006.02161.x. Epub 2006 Aug 8.
4
von Willebrand factor, endothelial dysfunction, and cardiovascular disease.
J Thromb Haemost. 2006 Jun;4(6):1186-93. doi: 10.1111/j.1538-7836.2006.01949.x.
5
Systemic antithrombotic effects of ADAMTS13.
J Exp Med. 2006 Mar 20;203(3):767-76. doi: 10.1084/jem.20051732. Epub 2006 Mar 13.
7
Plasma levels of von Willebrand factor regulate ADAMTS-13, its major cleaving protease.
Br J Haematol. 2004 Jul;126(2):213-8. doi: 10.1111/j.1365-2141.2004.05009.x.
9
Associations of plasma fibrinogen assays, C-reactive protein and interleukin-6 with previous myocardial infarction.
J Thromb Haemost. 2003 Nov;1(11):2312-6. doi: 10.1046/j.1538-7836.2003.00467.x.
10
von Willebrand factor and coronary heart disease: prospective study and meta-analysis.
Eur Heart J. 2002 Nov;23(22):1764-70. doi: 10.1053/euhj.2001.3237.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验